Primary Recipient

LELAND STANFORD JUNIOR UNIVERSITY, THE

Amount

$3,067,107.00

Award Date

9/28/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Intravenous (IV) administration of tissue plasminogen activator (tPA) is an effective and approved therapy for acute stroke when treatment is begun within 3 hours of symptom onset. Recent data suggest limited benefits up to 4.5 hours after symptom onset

Recipients Connected to Award

Recipient	Role	Amount
LELAND STANFORD JUNIOR UNIVERSITY, THE	Primary recipient	$1,492,415.00
UNIVERSITY OF PITTSBURGH THE	Sub-recipient	$522,056.00
UNIVERSITY OF UTAH, THE	Sub-recipient	$197,141.00
OREGON HEALTH & SCIENCE UNIVERSITY	Sub-recipient	$189,123.00
SWEDISH HEALTH SERVICES	Sub-recipient	$148,632.00
NORTHWESTERN UNIVERSITY	Sub-recipient	$140,142.00
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS	Sub-recipient	$138,670.00
THE QUEEN'S MEDICAL CENTER	Sub-recipient	$137,147.00
SAINT LUKE'S HOSPITAL OF KANSAS CITY	Sub-recipient	$96,615.00
UNIVERSITY OF SOUTH FLORIDA	Sub-recipient	$5,166.00